BIOGEN, ya darn speller - apologies to readers
Why logical? Nitrogen licenses what they want and let's Isis do the lifting - seems a far better way to spread risk & development costs.
this stock looks like a prime candidate to be shorted. Angiomax now has generic substitute that is making sales drop over the cliff and a new product being launched that has very weak science backing it - a good formula for "shorts"
Sentiment: Strong Sell
Only if some unanticipated bad news otherwise this summer slump of the entire market including the Fed's interest rise (idiot idea that will punish democrats in next election) will look like a decent entry point.
Nope, Pfizer has the record, shame that SNY thought they were better despite history.
Good points but having 4 partners with large sales groups plus PTLA' s own singing praises as a chorus means strong launch start (benefits all 5). Not having to bet on all 5 horses but concentrate my bet on the PTLA horse.
Had nothing to do with sales - had everything to do with the then CEO' s wife who hated being posted to the remote NW outpost called Seattle, she needed to be closer to her society witches therefore following the logic of "happy wife, happy life" the move to Chicago. Yep, it was really that simple but that many moons ago and many democratic party donations ago.
Seems you really don't care how or why the FDA; which is fine when you want to talk anecdotal soft points but don't try to rationalize a poor small study foreign as the "science" to justify your agenda.
Fine, how is this study statistically powered that "proves" what you claim for hemodialysis patients? The FACT is this study is not powered to be statistical and why this is minor factoid study. You might not like that but you really can't know if this just a chance finding without statistical significance. It only engenders anecdotal stories which is lousy basis for making an intelligent risk vs reward Rx decision.